Pharmaceuticals and the Developing World

Michael Kremer

Journal of Economic Perspectives, 2002, vol. 16, issue 4, 67-90

Abstract: Pharmaceuticals have greatly improved health in developing countries, but many people in developing countries do not obtain even inexpensive pharmaceuticals and little pharmaceutical R&D is oriented toward products needed by developing countries, such as a malaria vaccine. Access to existing products could be improved by facilitating differential pricing, for example by subsidizing donation programs, and reforming health care delivery. R&D incentives could be improved if rich countries or international organization committed to purchase needed products when they are developed and make them available to the poor.

Date: 2002
Note: DOI: 10.1257/089533002320950984
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (114)

Downloads: (external link)
http://www.aeaweb.org/articles.php?doi=10.1257/089533002320950984 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:aea:jecper:v:16:y:2002:i:4:p:67-90

Ordering information: This journal article can be ordered from
https://www.aeaweb.org/journals/subscriptions

Access Statistics for this article

Journal of Economic Perspectives is currently edited by Enrico Moretti

More articles in Journal of Economic Perspectives from American Economic Association Contact information at EDIRC.
Bibliographic data for series maintained by Michael P. Albert ().